PPD Development

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that treat cancer, cardiovascular and autoimmune diseases and viral infections. BioCryst uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry and computer modeling. In structure-based drug design, scientists use detailed knowledge of the active sites of protein targets associated with particular diseases to design synthetic compounds that fight the disease. Structure-based drug design aims to create a molecule that will bind to the active site of a targeted enzyme, thereby preventing the normal chemical reaction and ultimately halting the progression of the disease. BioCryst was founded in 1986. The Company's stock is traded on the NASDAQ exchange under the symbol BCRX.

Zinfandel Pharmaceuticals, Inc is a biopharmaceutical company based in Chapel Hill, NC, specializing in the research and development of innovative treatments for neurological disorders. With a focus on cutting-edge science and a commitment to improving patient outcomes, Zinfandel Pharmaceuticals, Inc is dedicated to advancing the field of neurology through its groundbreaking research and development efforts. Generated from their business information

Sandoz Inc is a pharmaceutical company based in Wilson, NC, specializing in the development and production of generic medications. With a focus on providing affordable healthcare solutions, Sandoz Inc is committed to improving access to high-quality pharmaceutical products for patients worldwide. Generated from their business information